Omi/HtrA2 is relevant to the selective vulnerability of striatal neurons in Huntington's disease
Omi/HtrA2 is relevant to the selective vulnerability of striatal neurons in Huntington's disease
复制标题
DOI:
10.1111/j.1460-9568.2008.06323.x
复制
发表时间:
2008-07-01
影响因子:
3.4
通讯作者:
Okazawa, Hitoshi
中科院分区:
文献类型:
--
作者:
Inagaki, Reina;Tagawa, Kazuhiko;Okazawa, Hitoshi
Selective vulnerability of neurons is a critical feature of neurodegenerative diseases, but the underlying molecular mechanisms remain largely unknown. We here report that Omi/HtrA2, a mitochondrial protein regulating survival and apoptosis of cells, decreases selectively in striatal neurons that are most vulnerable to the Huntington's disease (HD) pathology. In microarray analysis, Omi/HtrA2 was decreased under the expression of mutant huntingtin (htt) in striatal neurons but not in cortical or cerebellar neurons. Mutant ataxin-1 (Atx-1) did not affect Omi/HtrA2 in any type of neuron. Western blot analysis of primary neurons expressing mutant htt also confirmed the selective reduction of the Omi/HtrA2 protein. Immunohistochemistry with a mutant htt-transgenic mouse line and human HD brains confirmed reduction of Omi/HtrA2 in striatal neurons. Overexpression of Omi/HtrA2 by adenovirus vector reverted mutant htt-induced cell death in primary neurons. These results collectively suggest that the homeostatic but not proapoptotic function of Omi/HtrA2 is linked to selective vulnerability of striatal neurons in HD pathology.